CAPITAL FUND MANAGEMENT S.A. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 133 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$181,000
-66.1%
24,600
-65.6%
0.00%
-85.7%
Q2 2015$534,000
-15.5%
71,592
-32.3%
0.01%
-22.2%
Q1 2015$632,000–105,700–0.01%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2015.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders